MIF and cancer: Our data showed that T cells cocultured with dendritic cells that had been infected with rSmeg-hMIF-hIL-7 could reduce secreted MIF levels via enhanced killing of MIF-producing cancer cells (figure 1), suggesting that the reduced MIF level found in mice vaccinated with rSmeg-hMIF-hIL-7 may be due to dual actions of anti-MIF antibodies and an enhanced CTL response.